CLEAN’s R&D, focused on innovation and sustainability, achieved key milestones in FY24, including the commercialization of HALS series and the development of pharma intermediates.
What is covered in the Full Insight:
Introduction to Clean Science & Technology
R&D Achievements and Future Growth Prospects
Financial and Capacity Expansion Plans
Market Position and Demand Projections
Valuation and Investment Outlook
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.